Company: AEMD
Filing Date: 2025-08-20
Form Type: S-1
Source: 0001683168-25-006352
Chunk: 56

Company: AETHLON MEDICAL INC
Filing Date: 2025-08-20
Form: S-1
Chunk 56
---
 times during the 90 days immediately
preceding that date) and do business in the State of Nevada directly or through an affiliated corporation, unless our articles of incorporation
or bylaws in effect on the tenth day after the acquisition of a controlling interest provide otherwise. These laws provide that a person
acquires a “controlling interest” whenever a person acquires shares of a subject corporation that, but for the application
of these provisions of the NRS, would enable that person to exercise (1) one fifth or more, but less than one third, (2) one third or
more, but less than a majority or (3) a majority or more, of all of the voting power of the corporation in the election of directors.
Once an acquirer crosses one of these thresholds, shares which it acquired in the transaction taking it over the threshold and within
the 90 days immediately preceding the date when the acquiring person acquired or offered to acquire a controlling interest become “control
shares” to which the voting restrictions described above apply.

NRS 78.139 also provides that
directors may resist a change or potential change in control of the corporation if the board of directors determines that the change or
potential change is opposed to or not in the best interest of the corporation upon consideration of any relevant facts, circumstances,
contingencies or constituencies pursuant to NRS 78.138(4).

In addition, our authorized but
unissued shares of common stock are available for our Board of Directors to issue without stockholder approval. We may use these additional
shares for a variety of corporate purposes, including future public or private offerings to raise additional capital, corporate acquisitions
and employee benefit plans. The existence of our authorized but unissued shares of common stock could render more difficult or discourage
an attempt to obtain control of our company by means of a proxy contest, tender offer, merger or other transaction. Our authorized but
unissued shares may be used to delay, defer or prevent a tender offer or takeover attempt that a stockholder might consider in its best
interest, including those attempts that might result in a premium over the market price for the shares held by our stockholders. The Board
of Directors is also authorized to adopt, amend or repeal our Bylaws, which could delay, defer or prevent a change in control.

Nasdaq Listing

Our common stock is listed on The Nasdaq Capital Market
under the symbol “AEMD.”

Transfer Agent

The transfer agent and registrar for our common stock